ACO Name and Location

KentuckyOne Health Partners, LLC
 Previous Names: N/A
1401 Harrodsburg Road, Suite B-395
Lexington, KY 40504

ACO Primary Contact

Primary Contact Name  Dorothy Lockhart
Primary Contact Phone Number  859.313.2390
Primary Contact Email Address Dorothy.Lockhart@CHISaintJosephHealth.org

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
KENTUCKY CARDIOLOGY, PLLC  N
EMMANUEL YUMANG, MD, PLLC  N
TAYLOR REGIONAL MEDICAL GROUP, LLC  N
THOMAS P. VON UNRUG MD INC  N
DOUGLAS NESBITT  N
TAYLOR COUNTY HOSPITAL DISTRICT HEALTH FACILITIES CORPORATION  N
SAINT JOSEPH HEALTH SYSTEM, INC.  N
FLAGET HEALTHCARE INC  N
KENTUCKYONE HEALTH MEDICAL GROUP INC  N

ACO governing body:

MEMBER Member’s Voting Power  

Membership Type

 

ACO Participant Legal Business Name/DBA if Applicable

Last Name First Name Title/Position
Houston Anthony FACHE/CEO 1 Vote ACO Participant Representative Saint Joseph Health System Inc.
Salley Robert MD 1 Vote ACO Participant Representative CHI Saint Joseph Medical Group Inc.
Coburn Thomas MD 1 Vote ACO Participant Representative CHI Saint Joseph Medical Group Inc.
Waldridge, II Ron MD (Chair) 1 Vote ACO Participant Representative Independent Provider
Qazi Mubashir MD 1 Vote ACO Participant Representative Kentucky Cardiology
Goulson Daniel MD/CMO 1 Vote ACO Participant Representative Saint Joseph Health System Inc.
Spitser Christy Treasurer 0 Vote Other Saint Joseph Health System Inc.
Knox Christi CRO 0 Vote Other Saint Joseph Health System Inc.
George William Secretary 0 Vote Other Saint Joseph Health System Inc.
Ewen Julianne DNP, APRN, FAANP 1 Vote ACO Participant Representative CHI Saint Joseph Medical Group Inc.
Von Unrug Thomas MD 1 Vote ACO Participant Representative Independent Provider
Rexroat Rose Voting Member 1 Vote Medicare Beneficiary Representative

Key ACO clinical and administrative leadership:

Dorothy Lockhart, MBA, MSN, RN ACO Executive
James Duncan, MD Medical Director
Christi Knox Compliance Officer
Thomas Coburn, MD Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name

Committee Leader Name and Position
 Executive Committee  Ron Waldridge, II, MD, Chair
 Governance Committee  James Duncan, MD, Chair
 Quality & Value Committee  Thomas Coburn, MD, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals
  • Hospital employing ACO professionals

Shared Savings and Losses Shared Savings Distribution

Amount of Shared Savings/Losses:

  • Second Agreement Period
    • Performance Year 2020, $3,298,000
  • First Agreement Period
    • Performance Year 2019, $12,029.38

Shared Savings Distribution:

  • Second Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: 28%
      • Proportion invested in redesigned care processes/resources: 30%
      • Proportion of distribution to ACO participants: 42%
  • First Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure: 80%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: N/A

     

    2020 Quality Performance Results

ACO # Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information  *  *
ACO-2 CAHPS: How Well Your Providers Communicate  *  *
ACO-3 CAHPS: Patients’ Rating of Provider  *  *
ACO-4 CAHPS: Access to Specialist  *  *
ACO-5 CAHPS: Health Promotion and Education  *  *
ACO-6 CAHPS: Shared Decision Making  *  *
ACO-7 CAHPS: Health Status/Functional Status  *  *
ACO-34 CAHPS: Stewardship of Patient Resources  *  *
ACO-45 CAHPS: Courteous and Helpful Office Staff  *  *
ACO-46 CAHPS: Care Coordination  *  *
ACO-14 Preventative Care and Screening: Influenza Immunization  66.73  76.03
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention  61.43  81.67
ACO-19 Colorectal Cancer Screen  66.67  72.59
ACO-20 Breast Cancer Screening  66.67  74.05
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease  76.69  83.37
ACO-27 Diabetes: Hemoglobin A1c Poor Control (>9%)  18.51  12.31
ACO-28 Controlling High Blood Pressure  73.67  74.70

*CMS waived the CAHPS for ACOs reporting requirement for Performance Year 2020 and will assign all ACOs automatic credit for each of the CAHPS survey measures within the patient/caregiver experience domain (85 FR 84472).  Additionally, the measures in the PCE domain are not eligible to earn Quality Improvement award points for Performance Year 2020.

*The extreme and uncontrollable circumstances policy was determined to apply to all counties in the United States during the quality reporting period for Performance Year 2020 (85 FR 84472). Accordingly, Shared Savings Program ACOs will receive the higher of the mean quality score across all ACOs or the ACO’s own quality score for Performance Year 2020; if an ACO does not report, it will receive the mean quality score.

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.

For Previous Year’s Financial and Quality Performance Results, please visit data.cms.gov

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR §425.612.

  • Waiver for Payment for Telehealth Services:
    • Our ACO clinicians do not provide telehealth services using the flexibilities under 42 CFR §425.612(f) and 42 CFR §425.613.

  • Beneficiary Incentive Program (BIP):
    • Our ACO does not use the Beneficiary Incentive Program (BIP) established under 42 CFR §425.304(c).